Sunshine Biopharma Inc Warrant
SBFMW
3 hedge funds and large institutions have $12.2K invested in Sunshine Biopharma Inc Warrant in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
77% more capital invested
Capital invested by funds: $6.87K → $12.2K (+$5.31K)
50% more funds holding
Funds holding: 2 → 3 (+1)
0.88% more ownership
Funds ownership: 2.14% → 3.02% (+0.88%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$6.37K |
| 2 |
CS
Clear Street
New York
|
+$21 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.44K |
SBFMW Hedge Fund Activity: Q1 2025 in Review
3 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q1 2025, worth a combined $12.2K — up 77% from $6.87K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SBFMW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $6.37K. The largest seller was Citadel Advisors, cutting an estimated $2.44K.
- 3 institutional investors held Sunshine Biopharma Inc Warrant (SBFMW) as of Q1 2025, up from 2 in Q4 2024.
- Funds reported $12.2K of Sunshine Biopharma Inc Warrant stock for Q1 2025, up 77% quarter-over-quarter.
- 1 fund opened new Sunshine Biopharma Inc Warrant positions in Q1 2025 and 0 closed out, a net change of +1 holder.
- The largest Sunshine Biopharma Inc Warrant buyer in Q1 2025 was UBS Group, an estimated $6.37K added.
- The largest Sunshine Biopharma Inc Warrant seller in Q1 2025 was Citadel Advisors, an estimated $2.44K sold.
Based on aggregated 13F filings for Q1 2025.